FIELD: medicine. SUBSTANCE: method involves injecting sclerosing agent into cyst cavity. The catheter is introduced into the papilla through lactiferous sinus and then into the lobar duct and cyst cavity. EFFECT: enhanced effectiveness in sclerosing lobar duct and cystic cavity communicating with it.
Title | Year | Author | Number |
---|---|---|---|
THERAPY OF LACTEAL CYSTS | 2007 |
|
RU2356513C1 |
METHOD OF UNILOCULAR NONPARASITIC SPLEEN CYST SURGERY IN CHILDREN | 2009 |
|
RU2402281C1 |
METHOD OF ULTRASOUND DIAGNOSTICS OF PRIMARY LOCALIZATION OF TUMORS WHICH CAUSE OBSTRUCTION IN DISTAL REGION OF COMMON BILE DUCT | 1997 |
|
RU2119299C1 |
SURGICAL METHOD FOR TREATING RECURRING OTHEMATOMA | 1997 |
|
RU2130300C1 |
METHOD FOR VERIFYING EARLY DIAGNOSES OF FIBROUS-CYSTIC DISEASE AND MAMMARY CANCER | 2004 |
|
RU2268475C2 |
METHOD FOR SURGICAL MANAGEMENT OF ERECTILE DYSFUNCTION CAUSED BY PATHOLOGICAL VENOUS DRAINAGE ALONG DEEP DORSAL VEIN OF PENIS | 2015 |
|
RU2574577C1 |
METHOD OF TREATING EXTERNAL PANCREATIC FISTULA | 2023 |
|
RU2819165C1 |
METHOD FOR TREATING CRYPTORCHISM IN COMBINATION WITH SECONDARY HYPOGONADISM | 2000 |
|
RU2192169C2 |
METHOD OF LAPAROSCOPIC TREATMENT OF VARICOCELE | 2019 |
|
RU2729431C1 |
METHOD FOR TREATING THE CASES OF SECONDARY HYPOGONADISM | 2000 |
|
RU2177735C1 |
Authors
Dates
2002-07-20—Published
2000-05-15—Filed